TrialBMC cancer2022

Effects of adding a neurokinin-1 receptor antagonist to 5 mg olanzapine, a 5-hydroxytryptamine-3 receptor antagonist, and dexamethasone for preventing carboplatin-induced nausea and vomiting: a propensity score-matched analysis.

Senri Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.